RB1 and retinoblastoma: For instance, regarding retinoblastoma, Liu and colleagues [24] genomically edited human embryonic stem cells (hESCs) with either homozygous RB1 loss-of-function mutation or deletion, and then differentiated these mutant cells into retinoblastoma organoids.